Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 23, 2021 | Elixiron Immunotherapeutics | $27.0M Series A Extension | Pangu Capital | CDIB Capital Group, Daiwa Corporate Investment, Fubon Ventures, Hong Tai Electric Industrial, Mega International Commercial Bank |
| May 5, 2021 | BridGene Biosciences | $12.0M Series A | Leilei Wang | Kaitai Capital, Takeda Ventures |